Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about company updates

12 Dec 2017 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..